Skip to main content
Clinical Trials/NCT05426590
NCT05426590
Unknown
Not Applicable

Evaluation of Corneal Endothelial Changes After Uneventful Phacoemulsification in Diabetic and Non-diabetic Patients in Relation to the Level of Glcosylated Hemoglobin Level

Marwa Ahmed1 site in 1 country68 target enrollmentMay 20, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Corneal Endothelial Changes After Phacoemulsification
Sponsor
Marwa Ahmed
Enrollment
68
Locations
1
Primary Endpoint
Defferentiate patients into diabetic and non-diabetic patients according to the endothelial changes after uneventful phacoemulsification
Last Updated
3 years ago

Overview

Brief Summary

Evaluation of corneal endothelial changes after uneventful phacoemulsification in diabetic and non-diabetic patients using specular biomicroscopy in relation to the level of glcosylated hemoglobin level

Detailed Description

86 patients will be divided into two equal groups of diabetic and non-diabetic patients will undergo phacoemulsification of cataract will be evaluated thier endocelium before surgery and 3 weeks after surgery to detect the effect of level of glcosylated hemoglobin on the endothelial changes after uneventful phacoemulsification

Registry
clinicaltrials.gov
Start Date
May 20, 2022
End Date
November 17, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Marwa Ahmed
Responsible Party
Sponsor Investigator
Principal Investigator

Marwa Ahmed

Clinical professor

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Diabetics and non-diabetic patients undergo cataract surgery
  • Age between 50-60 years old
  • Corrected distance visual acuity\<0.4
  • Gender: both genders.

Exclusion Criteria

  • Chronic Ocular diseases (glaucoma,uveitis, amblyopia, strabismus,keratoconus, corneal opacity).
  • corneal dystrophy History of previous keratitis or viral corneal infection. Corneal dystrophy Ocular trauma. Previous ocular surgery. Complicated cataract surgery

Outcomes

Primary Outcomes

Defferentiate patients into diabetic and non-diabetic patients according to the endothelial changes after uneventful phacoemulsification

Time Frame: 6 monthes

Detect effect of glycosylated hemoglobin level after uneventful phacoemulsification in diabetic and non-diabetic patients

Study Sites (1)

Loading locations...

Similar Trials